About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

KUALA LUMPUR, Malaysia, April 15, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a diversified biotechnology and specialty materials group headquartered in Malaysia and incorporated in Wyoming, today announced the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission.

The Company’s 2024 report showcases a year of strategic realignment, technological advancement, and enhanced corporate governance - positioning BGLC for sustainable long-term growth.

Financial Resilience and Market Stability

BGLC ended 2024 with a strong cash position of over $4million and total liquidity exceeding $6 million, reinforcing the Company’s commitment to prudent capital management. Despite macroeconomic headwinds, BioNexus reduced its year-over-year net loss by over 39%, reflecting improved operational efficiency and cost discipline across its healthcare diagnostics and specialty chemicals divisions.

Breakthrough Innovation in Digital Health and Blockchain

The Company marked a significant milestone by approving a blockchain-native treasury strategy, becoming the first Nasdaq-listed issuer to prioritize Ethereum (ETH) as a core strategic reserve asset. This forward-looking initiative is intended to enhance capital efficiency while aligning with emerging digital infrastructure standards - particularly within the U.S. and Wyoming's evolving Web3 regulatory frameworks.

Additionally, the Company continued to expand its genomic diagnostics offerings under its MRNA Scientific division and entered into strategic partnerships to scale its molecular screening platform and AI-based health diagnostics initiatives.

Nasdaq Compliance

To maintain its Nasdaq listing, the Company effected a 1-for-10 reverse stock split on April 7, 2025. The Company expects to regain full compliance with the Nasdaq minimum bid price rule by or before the May 1, 2025 deadline.

CEO Commentary

"2024 was a foundational year for BioNexus," said Sam Tan, CEO and President of BGLC. "We emerged from operational restructuring with renewed strategic focus, maintaining a clean balance sheet, and the conviction to lead in both healthcare technology and decentralized finance. We look forward to executing on our growth roadmap and building long-term shareholder value."

About BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. (Nasdaq: BGLC) is a Wyoming-incorporated, Nasdaq-listed company with operating subsidiaries in Malaysia focused on molecular diagnostics and chemical raw materials distribution. Through its wholly owned subsidiaries, MRNA Scientific and Chemrex Corporation, BGLC is dedicated to improving healthcare through advanced genomics and providing high-quality composite materials to industrial sectors across Southeast Asia.

For more information, please visit www.bionexusgenelab.com

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, including those related to Nasdaq compliance, future expansion, revenue growth, blockchain adoption, and strategic partnerships, involve known and unknown risks, uncertainties, and other important factors. Actual results may differ materially. The Company undertakes no obligation to update any forward-looking statements except as required by law.

Investor Relations Contact:
ir@bionexusgenelab.com
+1 (307) 241-6898


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.